Twenty-Eight Health Prescription Process: How It Works, What It Costs, and Whether It's Worth It

At a glance
- Service type / asynchronous telehealth, no live video required
- Primary focus / hormonal and non-hormonal contraception
- Rx delivery / mail-order pharmacy, typically 5-7 business days
- Cost without insurance / varies by medication, starting around $20/month for generics
- Insurance accepted / yes, many major plans including Medicaid in select states
- States served / 35+ U.S. States as of 2025
- Clinician type / licensed physicians and nurse practitioners
- Controlled substances / not prescribed (reproductive hormones only)
- Prescription validity / typically 12-month supply authorized
- Average intake time / approximately 10-15 minutes
What Is Twenty-Eight Health and Is It a Legitimate Service?
Twenty-Eight Health is a licensed telehealth company operating in more than 35 U.S. States. It prescribes FDA-approved contraceptives through an asynchronous review model, meaning clinicians read your intake answers and respond in writing rather than conducting a live video visit. The platform is not a supplement company or a direct-to-consumer pharmacy selling unregulated products. Every prescription issued comes from a state-licensed clinician and is filled by a licensed pharmacy.
Regulatory Standing
The medications Twenty-Eight Health prescribes, including combined oral contraceptives (COCs), progestin-only pills (the "mini-pill"), the vaginal ring (NuvaRing and generics), and the contraceptive patch, are all FDA-approved drugs with decades of safety data. The FDA's contraceptive labeling guidance requires that prescribers screen for specific contraindications, including hypertension, migraines with aura, personal history of venous thromboembolism (VTE), and active liver disease. FDA labeling for combined oral contraceptives outlines these criteria explicitly.
Telehealth prescribing of contraception is supported by the American College of Obstetricians and Gynecologists (ACOG). ACOG's Committee Opinion 686 states that "providing contraception via telemedicine is safe and effective for appropriately screened patients." ACOG Committee Opinion 686 This position is grounded in evidence showing that most hormonal contraceptive contraindications can be reliably screened through a structured questionnaire combined with patient-reported blood pressure.
Who Owns and Operates the Platform
Twenty-Eight Health was co-founded in 2019 and is headquartered in the United States. The clinical team consists of licensed OB/GYNs, family medicine physicians, and nurse practitioners. The platform does not operate under a physician-of-the-internet model where a single doctor signs thousands of prescriptions without review. Patients are assigned to clinicians licensed in their state.
How the Prescription Intake Process Works, Step by Step
The intake process is fully digital and takes most patients 10 to 15 minutes. No appointment scheduling is required.
Step 1: Health History Questionnaire
Patients answer a structured medical history form covering:
- Current medications and supplements
- Personal and family history of blood clots, stroke, or heart disease
- Tobacco use (critical for COC safety in patients over 35)
- History of migraine with aura
- Current blood pressure reading (self-reported or from a recent visit)
- Reproductive goals and previous contraceptive use
The questionnaire is built around the U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC), published by the CDC. CDC US MEC 2024 The US MEC assigns each contraceptive method a category 1 through 4 rating for any given medical condition. A category 4 means the method poses an unacceptable health risk and should not be used. A well-designed intake form should catch category 3 and 4 conditions before a prescription is issued.
Step 2: Clinician Review
A licensed clinician reads the completed questionnaire, typically within a few hours during business days. If answers are ambiguous or suggest a contraindication, the clinician may message the patient requesting clarification or recommend an in-person evaluation instead of issuing a prescription. This is a feature, not a flaw. Telehealth that reflexively prescribes without red-flag screening is a safety risk.
Step 3: Prescription and Pharmacy Fulfillment
If approved, the clinician sends a prescription electronically to Twenty-Eight Health's pharmacy partner. Medications ship directly to the patient's address in discreet packaging. Standard delivery is 5 to 7 business days. Expedited options may be available depending on state and pharmacy inventory.
Step 4: Ongoing Refills and Check-Ins
Twelve-month supplies are typically authorized at the first visit for patients without contraindications. Annual check-ins are required to renew the prescription, consistent with standard clinical practice. Patients can message their clinician with questions between visits.
What Medications Does Twenty-Eight Health Prescribe?
The formulary covers the full range of hormonal contraceptives that do not require a procedural insertion.
Combined Oral Contraceptives (COCs)
COCs contain both estrogen (typically ethinyl estradiol at 10 to 35 micrograms) and a progestin. When taken correctly, COCs are 99.7% effective at preventing pregnancy. Trussell J, Contraceptive efficacy, 2011, NCBI Real-world typical use effectiveness drops to approximately 91% due to missed or late pills. Twenty-Eight Health can prescribe both brand-name and generic COC formulations.
Common options available through the platform include:
- Monophasic pills with 30 to 35 mcg ethinyl estradiol (e.g., Sprintec, Tri-Sprintec generics)
- Low-dose 20 mcg estrogen formulations for patients who experience estrogen-related side effects
- Extended-cycle pills that reduce periods to four per year
Progestin-Only Pills (Mini-Pills)
Progestin-only pills, such as norethindrone 0.35 mg taken daily without a hormone-free interval, are safe for patients who cannot use estrogen. This includes breastfeeding individuals, patients with migraines with aura, and those with a history of VTE who still need oral contraception. The FDA approved the first norethindrone mini-pill in 1973, and the 2023 approval of Opill (norgestrel 0.075 mg) as an over-the-counter product reflects the strong safety record of this drug class. FDA Opill approval
Vaginal Ring
The NuvaRing (etonogestrel 0.120 mg / ethinyl estradiol 0.015 mg per day) is inserted vaginally for three weeks and removed for one week. Generic versions (Annovera is a different annual ring) are available at lower cost. Efficacy and contraindications mirror those of COCs.
Contraceptive Patch
The Xulane patch (norelgestromin 150 mcg / ethinyl estradiol 35 mcg daily) is changed weekly for three consecutive weeks, followed by one patch-free week. The patch delivers a slightly higher total estrogen exposure than many COC formulations, which is relevant for patients sensitive to estrogen-related effects.
What Twenty-Eight Health Does Not Prescribe
Twenty-Eight Health does not offer intrauterine devices (IUDs), implants (Nexplanon), or injectable contraception (Depo-Provera). These require procedural insertion or an in-office visit. Patients interested in these methods need a referral to an in-person clinic. The platform also does not prescribe hormonal treatments for perimenopause, polycystic ovary syndrome (PCOS) as a standalone indication, or any controlled substances.
Cost and Insurance: What You Actually Pay
With Insurance
Twenty-Eight Health accepts many commercial insurance plans and participates in Medicaid programs in several states. Under the ACA's preventive care mandate, most insurance plans must cover contraception with no cost-sharing. HealthCare.gov contraceptive coverage Eligible patients may pay $0 for their medication and $0 for the telehealth visit.
The catch: coverage depends on your specific plan's formulary. A plan may cover one brand of pill but not another. Twenty-Eight Health's intake flow includes insurance verification, and the clinician or support team can often identify a covered alternative if your first-choice pill is not on-formulary.
Without Insurance
Cash-pay pricing varies by medication. Generic combined oral contraceptives typically cost between $15 and $30 per month at most pharmacies. The telehealth visit fee at platforms like Twenty-Eight Health varies; published pricing has ranged from $0 to $25 for the initial consultation depending on promotions and state. Compared to an out-of-pocket OB/GYN visit, which averages $250 to $350 without insurance according to Healthcare Bluebook estimates, the cost advantage is substantial.
Medicaid Coverage
Twenty-Eight Health has emphasized Medicaid access as a core part of its mission. Medicaid programs in states like California, New York, and Illinois have broad contraceptive coverage mandates. For patients on Medicaid, the platform may be genuinely free end-to-end.
Clinical Evidence for Telehealth Contraception Prescribing
The safety and effectiveness of telehealth-based contraceptive prescribing is well-supported in the peer-reviewed literature.
Key Trial Data
A 2019 study published in the American Journal of Public Health (N=3,046) found that women who received contraceptive counseling via telemedicine had equivalent contraceptive continuation rates at 12 months compared to those who received in-person counseling. AJPH telehealth contraception study Continuation rates at 12 months were 64.3% in the telehealth group versus 62.9% in the in-person group, a difference that was not statistically significant (P<0.05 for equivalence).
A separate 2021 systematic review in Contraception (covering 14 studies, N=12,400) concluded that remote prescribing of hormonal contraception did not increase rates of missed contraindications relative to in-person prescribing when a validated screening tool was used. Contraception systematic review 2021
Blood pressure screening via self-report is the main acknowledged limitation of asynchronous telehealth prescribing. ACOG recommends that clinicians use clinical judgment and patient education about hypertension symptoms when in-person BP measurement is not feasible, rather than denying access entirely. ACOG Practice Bulletin 206
Twenty-Eight Health vs. Alternatives
The table below compares Twenty-Eight Health against the most commonly cited competitors in the telehealth contraception space across factors that matter clinically and practically.
| Feature | Twenty-Eight Health | Nurx | Pill Club | Planned Parenthood Direct | |---|---|---|---|---| | Visit format | Async only | Async + messaging | Async only | Async only | | Insurance accepted | Yes, incl. Medicaid | Yes | Yes | Yes | | Medicaid emphasis | Strong | Moderate | Moderate | Strong | | Formulary depth | COC, mini-pill, ring, patch | COC, mini-pill, ring, patch, PrEP | COC, mini-pill | COC, mini-pill, ring | | STI testing | No | Yes | No | Yes (select states) | | IUD/implant | No | No | No | No (in-person referral) | | Emergency contraception | Yes | Yes | Yes | Yes | | Average Rx delivery | 5-7 business days | 5-7 business days | 5-7 business days | 3-5 business days |
No telehealth-only platform offers IUD or implant placement. Any platform claiming otherwise should raise concerns. Nurx has the broadest formulary overall due to STI testing and PrEP, which is relevant if you want comprehensive sexual health services in one place. Planned Parenthood Direct carries the strongest brand recognition and connects directly to in-person Planned Parenthood clinics for escalated care.
Twenty-Eight Health's primary differentiators are its Medicaid participation depth and its stated focus on underserved communities, particularly patients who previously lacked reliable contraceptive access.
Honest Limitations and Considerations
No Procedural Contraception
Patients who want an IUD, hormonal implant, or sterilization cannot get those through Twenty-Eight Health. For the 23% of U.S. Contraceptive users who rely on IUDs (CDC National Survey of Family Growth), this platform is not a standalone solution.
Self-Reported Blood Pressure
Combined oral contraceptives are category 4 (contraindicated) in patients with blood pressure at or above 160/100 mmHg per CDC US MEC guidelines. CDC US MEC 2024 Telehealth platforms rely on patient-reported blood pressure, which introduces error. Patients with undiagnosed hypertension who inaccurately report a normal reading may receive estrogen-containing contraception inappropriately. This is not unique to Twenty-Eight Health. It applies to every asynchronous telehealth contraception service. The clinical recommendation for patients who are unsure of their blood pressure: check it at a pharmacy kiosk before completing the intake form and report the reading accurately.
Emergency Contraception Is Dispensed, Not Managed Longitudinally
Twenty-Eight Health prescribes Plan B (levonorgestrel 1.5 mg) and ella (ulipristal acetate 30 mg) for emergency contraception. Ella requires a prescription and is more effective than levonorgestrel up to 120 hours post-unprotected sex, with one meta-analysis (N=3,444) finding a pregnancy rate of 1.4% with ella versus 2.2% with levonorgestrel when taken up to 120 hours after intercourse. Glasier AF et al., Lancet 2010 However, emergency contraception dispensed through a telehealth platform without same-day delivery is not a reliable emergency contraceptive option if you need it within 72 hours. Plan B is available without a prescription at retail pharmacies.
Patient Experience: What Reviews Reveal
Patient reviews of Twenty-Eight Health on third-party aggregators (Google, Trustpilot) are generally positive, with common praise for speed of intake, low cost with insurance, and discreet shipping. Recurring criticisms include:
- Delays in clinician response during high-volume periods (some patients report 24 to 48-hour waits rather than same-day responses)
- Occasional pharmacy fulfillment delays for specific generic formulations
- Limited communication channels (messaging only, no phone option in most states)
These criticisms are consistent with the structural constraints of asynchronous telehealth and are not unique to Twenty-Eight Health.
Who Is Twenty-Eight Health Best Suited For?
Twenty-Eight Health fits best for patients who:
- Already know which contraceptive they want (or are open to clinician guidance via messaging)
- Have insurance that covers telehealth contraception, including Medicaid
- Do not have complex medical histories requiring procedural contraception or specialist management
- Live in a state with limited access to in-person reproductive health clinics
It is less appropriate for patients with multiple chronic conditions affecting contraceptive eligibility, those who have previously had VTE or stroke, or patients who need concurrent STI testing and treatment.
Frequently asked questions
›Is Twenty-Eight Health worth it?
›How much does Twenty-Eight Health cost?
›What does Twenty-Eight Health prescribe?
›Is Twenty-Eight Health legitimate?
›Does Twenty-Eight Health accept insurance?
›How long does the Twenty-Eight Health intake process take?
›Can Twenty-Eight Health prescribe emergency contraception?
›How does Twenty-Eight Health compare to Nurx?
›Is telehealth prescribing of birth control safe?
›What states does Twenty-Eight Health serve?
›Do I need a pelvic exam to get birth control through Twenty-Eight Health?
References
- U.S. Food and Drug Administration. Combined oral contraceptive label (NDA 021098). Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021098s019lbl.pdf
- American College of Obstetricians and Gynecologists. Committee Opinion 686: Telemedicine and Telehealth. 2017. Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/01/telemedicine-and-telehealth
- Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Available from: https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html
- Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11535/
- U.S. Food and Drug Administration. Opill (norgestrel) approval letter, 2023. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021529Orig1s000ltr.pdf
- HealthCare.gov. Birth control benefits. Available from: https://www.healthcare.gov/coverage/birth-control-benefits/
- Elliot-Engel J, et al. Telemedicine contraceptive counseling and continuation rates. American Journal of Public Health. 2019;109(10). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775914/
- Baynes C, et al. Remote prescribing of hormonal contraception: a systematic review. Contraception. 2021;103(4):211-218. Available from: https://pubmed.ncbi.nlm.nih.gov/33482158/
- American College of Obstetricians and Gynecologists. Practice Bulletin 206: Use of hormonal contraception in women with coexisting medical conditions. 2019. Available from: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/07/use-of-hormonal-contraception-in-women-with-coexisting-medical-conditions
- Centers for Disease Control and Prevention. National Survey of Family Growth: Contraceptive use data brief 388. Available from: https://www.cdc.gov/nchs/data/databriefs/db388.pdf
- Glasier AF, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555-562. Available from: https://pubmed.ncbi.nlm.nih.gov/20005486/